2025-05-02 04:51:28
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Krebs Biochemicals and Industries Ltd Q2FY23 loss reduces to Rs. 4.06 crores
Posted On : 2022-11-11 22:31:31( TIMEZONE : IST )
Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 21.2171 crores during the period ended September 30, 2022 as compared to Rs. 10.7699 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. -4.0614 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. -8.1367 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. -1.88 for the period ended September 30, 2022 as compared to Rs. -3.77 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 21.2171 crs | ₹10.7699 crs |  97.00% |
| Net Profit | ₹-4.0614 crs | ₹-8.1367 crs |  50.09% |
| EPS | ₹-1.88 | ₹-3.77 | 50.13% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 21.2171 crores during the period ended September 30, 2022 as compared to Rs.12.1121 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.-4.0614 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.-10.8485 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.-1.88 for the period ended September 30, 2022 as compared to Rs.-5.05 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 21.2171 crs | ₹12.1121 crs | 75.17% |
| Net Profit | ₹-4.0614 crs | ₹-10.8485 crs | 62.56% |
| EPS | ₹-1.88 | ₹-5.05 | 62.77% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.31.9870 crores during the 6 Months period ended September 30, 2022 as compared to Rs.18.8973 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.-12.1980 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.-20.2720 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.-5.66 for the 6 Months period ended September 30, 2022 as compared to Rs.-9.42 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹31.9870 crs | ₹18.8973 crs | 69.27% |
| Net Profit | ₹-12.1980 crs | ₹-20.2720 crs | 39.83% |
| EPS | ₹-5.66 | ₹-9.42 | 39.92% |
Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 112.90 as compared to the previous close of Rs. 112.00. The total number of shares traded during the day was 490 in over 18 trades.
The stock hit an intraday high of Rs. 115.25 and intraday low of 112.35. The net turnover during the day was Rs. 55533.00.
